Application 210083
- Type
- ANDA
- Sponsor
- RICONPHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50742-486 | GLYCOPYRROLATE | Glycopyrrolate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-487 | GLYCOPYRROLATE | Glycopyrrolate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-488 | GLYCOPYRROLATE | Glycopyrrolate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-489 | GLYCOPYRROLATE | Glycopyrrolate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 70860-781 | Glycopyrrolate | glycopyrrolate | Athenex Pharmaceutical Division, LLC. | ANDA | Current |